Cognitive Assessment And Training In Healthcare Market Size, Share & Trends Analysis Report Analysis By Assessment (Biometrics, Pen & Paper-based Assessment), By Component, By Application, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global cognitive assessment and training in healthcare market size was estimated at USD 4.3 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 26.1% from 2023 to 2030. The increasing incidence of dementia, rising awareness of cognitive health, and growing adoption of technologically advanced cognitive assessment & training tools are some of the key factors expected to drive the industry’s growth over the forecast period. The COVID-19 pandemic had a significant influence on cognitive assessment and training with disruptions in the supply chain of hardware components required for computer-based assessment and training tools. In the early phase of the pandemic, some countries implemented lockdowns that significantly hampered the ability to carry out routine cognitive assessments and medical treatments in hospitals. The market experienced a minor decline for a short span in 2020. However, it is now on a positive trajectory with major signs of recovery.

The demand for online cognitive assessment and training solutions increased during the pandemic due to better access to technology and the adoption of telehealth, thus mitigating the losses experienced during the initial phase of the pandemic. As neurological impacts have been observed in COVID-19 patients, tracking cognitive capacity has become a crucial activity, thus contributing to market growth.

According to Alzheimer’s Association, more than 153 million individuals will develop dementia by 2050, up from 57 million in 2019. The anticipated increase is mainly due to the growing geriatric population. According to data published by the World Health Organization in February 2019, the total geriatric population in the world is anticipated to reach 1.4 billion by 2030.

As mobile technologies become more accessible, they are increasingly being used in cognitive assessment and clinical research for patient recruitment, data collection, symptom monitoring, and health management. Gamification and serious activity for health self-monitoring and management have experienced a significant increase in popularity in the healthcare sector. In 2022, the University of Oxford collaborated with Cambridge Cognition for the Impact of Semaglutide in Amyloid Positivity (ISAP) study to provide cognitive assessments.

Numerous apps have been created to train the brain and challenge the brain, and health-related apps make up a significant portion of this industry. For instance, CogniFit is an interactive game and brain-training app designed to help develop up to 22 more skills, including attention, processing speed, concentration, reaction time, and more. It also helps to improve short-term memory.

Assessment Insights

The pen & paper-based assessment segment dominated the cognitive assessment and training in healthcare market with a revenue share of 47.5% in 2022 owing to easy availability and affordability. Although they require more time to administer, they offer the advantage of testing more cognitive capabilities. The results of the tests, which evaluate different aspects of cognitive functioning including short-term memory, attention, concentration, working memory, visual-spatial ability, reaction time, and information processing speed, can help clinicians gauge the severity of a brain injury and cognitive impairment.

The hosted assessment segment is expected to witness a CAGR of 26.6% over the forecast period owing to better access to technology, growing adoption of telehealth, and increasing adoption of mobile technology for gamification in cognitive assessment and training. In addition, computerized cognitive assessments continue to become reimbursable over time using CPT codes due to the latest advancements in neuropsychological testing. Hosted assessment makes it possible for a medical assistant as well as other non-specialized staff members to deliver assessments reliably, potentially assisting neurologists in doing better assessments and treating more patients.

Component Insights

In 2022, the services component held the largest revenue share of more than 50.0% owing to an increase in the demand for advanced services offered by market players. Companies are offering services such as training & support, and consulting for rater qualification, training, and management that equip raters to administer scales most efficiently while adhering to the highest standards. For instance, the experimental technique used by Cogstate, a U.S.-based company, removes pointless training, makes use of a tailored eLearning curriculum, lessens the burden of rater certification, and speeds up the commencement of a study.

The solution segment is expected to witness a CAGR of around 20.0% over the forecast period, owing to an increase in the number of technologically advanced solutions offered by market players. Various solutions offered by businesses are digital assessments, data analysis & reporting, and data management. Market players offer online data management solutions in addition to digital cognitive assessment tools for effective data storage and continuing management of data discrepancies. Researchers and healthcare professionals can instantly access the results after uploading cognitive test data, enabling effective review, cleaning, and analysis.

Application Insights

The clinical trials segment held a majority of the revenue share of 41.2% in 2022 and is expected to retain its position during the forecast period. Clinical drug safety and efficacy testing is extremely difficult when treating the central nervous system. Study teams can improve the success rate of their trials by using cognitive assessments to make quicker and more informed judgments about their potential therapeutic drug. Numerous organizations provide objective assessments and solutions that aid thousands of researchers working on different symptoms and stages of the development of any drug. Market players support clinical trials by providing validated and sensitive computerized cognitive assessments tested rater training and data quality systems.

The screening & diagnostics segment is likely to witness a significant CAGR of 26.2% over the forecast period. Cognitive assessments are ideal as an effective screening tool to support collaboration with neuropsychologists, neurosurgeons, and other specialists to make evidence-based decisions about the next-best steps in the treatment of a patient. Neurologists can more effectively pinpoint deficiencies and strengthen the help in diagnosis and subsequently monitor recovery as therapy continues with the help of a quantitative assessment of a patient's brain health.

Regional Insights

North America held a leading revenue share of 37.7% in 2022. The increasing prevalence of dementia, the adoption of technologically advanced assessment tools, and significant expenditure on cognitive research are some of the factors attributed to the market growth. There has been a steady growth in the number of patients with cognitive impairment in the region, fueling the demand for cognitive assessment. Government initiatives such as Aging's Alzheimer's Disease Supportive Services Program support state efforts to develop adaptive, comprehensive, and sustainable service delivery systems for patients with Alzheimer's disease. In June 2022, LifeWorks launched an internet-based cognitive behavioral therapy (iCBT) program in Canada & the U.S. to address signs of burnout for workers in the healthcare sector.

Asia Pacific is expected to grow at the fastest CAGR of 27.0% during the forecast period due to the rising geriatric population, increasing prevalence of dementia, increasing incidence of sports injuries & trauma leading to cognitive impairment, rapidly expanding healthcare infrastructure, and growing government support. According to Alzheimer's Disease International, it is estimated that around 71 million people in the Asia Pacific are likely to have dementia by 2050. In addition, TALi Digital Limited, a digital health company, signed an advertising & investment agreement with strategic investment firm Brand Capital International (BCI), to launch support programs in India for children’s mental health & wellness.

Key Companies & Market Share Insights

Leading industry players are adopting strategies such as new launches, partnerships, collaborations, acquisitions, mergers, and agreements to survive the highly competitive environment and expand their business footprints. For instance, in January 2022, Eisai Co., Ltd. announced the launch of CogMate by its Taiwanese and Hong Kong subsidiary. CogMate is a digital tool for self-assessment of brain health and is expected to be launched in other countries including Singapore.

Koninklijke Philips N.V. launched IntelliSpace Cognition in November 2019, which combines the cloud-based HealthSuite digital platform and AI to assess cognitive impairment. It can perform a wide range of tests. The company has benefited by entering this market and capturing market share, which has helped it gain revenue.

The key players are focused on product innovation and strategic partnerships to strengthen their competitive strengths while expanding their global reach. For instance, the U.S.-based publisher of clinical and educational standardized tests, Riverside Insights, owned by Alpine Investors, acquired ImPACT Applications, Inc., in January 2020. Alpine continues its strategy of partnering with companies within the education and healthcare sectors to catalyze growth.

Riverside strengthens its healthcare and education offerings with the acquisition of ImPACT Applications. ImPACT Applications, Inc. provides research-backed assessments related to concussions. The company assesses processing speed, memory function, and visual-motor abilities with FDA-cleared post-concussion assessments and cognitive testing for the age group of 12 to 59 years. Some prominent players in the global cognitive assessment and training in healthcare market include:

• Cambridge Cognition Ltd

• CogniFit Inc

• Cogstate Ltd

• CNS Vital Signs, LLC

• Brain Resource Company

• WIRB-Copernicus Group

• Quest Diagnostics Incorporated

• Signant Health

• Posit Science

• Clario

• Cognetivity Neurosciences

Cognitive Assessment And Training In Healthcare Market Report Scope

Global Cognitive Assessment And Training In Healthcare Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global cognitive assessment and training in healthcare market report based on assessment, component, application, and region:

• Assessment Outlook (Revenue, USD Million, 2018 - 2030)

  • Biometrics Assessment

  • Pen & Paper-based Assessment

  • Hosted Assessment

• Component Outlook (Revenue, USD Million, 2018 - 2030)

  • Solution

    • Assessment

    • Data Analysis & Reporting

    • Data Management

    • Others

  • Services

    • Training & Support

    • Consulting

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Clinical Trials

  • Screening & Diagnostics

  • Brain Training

  • Academic Research

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait